阿拉基酸和素A4保护胰腺β细胞,改善由白素诱导的高血糖症
Sailaja Polavarapu1, Poorani Rhenghachar1, Undurti N Das1,2,3,4
1BioScience Research Centre, GVP Engineering College, Visakhapatnam, India.
Journal of biochemical and molecular toxicology
|February 23, 2026
概括
阿拉基酸 (AA) 和其代谢物利素A4 (LXA4) 保护胰腺β细胞免受白胺诱导的损伤. 这些化合物还逆转了高血糖症,并改善了大鼠的基因表达,这表明了治疗潜力.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 内分泌学 在内分泌学.
背景情况:
- 布莱奥米辛可以诱导胰腺β细胞功能障碍和高血糖症.
- 阿拉基酸 (AA) 和其代谢物利素A4 (LXA4) 具有抗炎性质.
- 对于AA和LXA4在减轻白血素诱导作用中的作用尚不清楚.
研究的目的:
- 研究AA和LXA4在RIN5F细胞中对白血素诱导的生长抑制的保护作用.
- 确定AA和LXA4对白血素诱导的高血糖在雌性Wistar大鼠的影响.
主要方法:
- 使用RIN5F细胞和MTT试验进行体外研究,以评估细胞活力.
- 在雌性Wistar大鼠体内研究以测量血糖和血胰岛素水平.
- 在治疗后对抗氧化剂状态和基因表达 (IκB,Bcl2) 的分析.
主要成果:
- AA和LXA4证明了RIN5F细胞对白血素诱导的生长抑制的显著保护.
- 在老鼠中,LXA4的使用逆转了白血素诱导的高血糖症,并使血胰岛素水平正常化.
- AA和LXA4治疗改善了抗氧化剂状态,并提高了抗炎和抗亡基因的调节.
结论:
- AA和LXA4有效地保护胰腺β细胞免受白胺诱导的损伤.
- AA和LXA4具有预防或治疗白素诱导的胰腺β细胞功能障碍和高血糖症的潜力.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
770
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
770
Insulin: Biosynthesis, Chemistry, and Preparation
1.6K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.6K
Chronic Pancreatitis I: Introduction
784
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
784
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Acute Pancreatitis II: Clinical Manifestations and Management
937
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
937
Hormones Regulating Blood Glucose
7.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.3K


